Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression
Chinese Journal of Integrative Medicine · 2024
DOI: 10.1007/s11655-024-4109-6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Integrative Medicine, 2024. Verfasst von Gang-Gang Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Henan Key Laboratory of Helicobacter pylori, Microbiota and Gastrointestinal Cancers, Marshall Medical Research Center, Fifth Affiliated Hospital of …. Hauptthemen laut MEDLINE: Flavonoids, Colonic Neoplasms, Molecular Docking Simulation, Cell Proliferation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 53 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: To observe the therapeutic effects and underlying mechanism of baicalin against colon cancer. METHODS: The effects of baicalin on the proliferation and growth of colon cancer cells MC38 and CT26. WT were observed and predicted potential molecular targets of baicalin for colon cancer therapy were studied by network pharmacology. Furthermore, molecular docking and drug affinity responsive target stability (DARTS) analysis were performed to confirm the interaction between potential targets and baicalin. Finally, the mechanisms predicted by in silico analyses were experimentally verified in-vitro and in-vivo. RESULTS: Baicalin significantly inhibited proliferation, invasion, migration, and induced apoptosis in MC38 and CT26 cells (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Henan Key Laboratory of Helicobacter pylori, Microbiota and Gastrointestinal Cancers, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 400015, China.
- Henan Key Laboratory of Helicobacter pylori, Microbiota and Gastrointestinal Cancers, Marshall Medical Research Center, Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, 400015, China. pyzheng@zzu.edu.cn.
Zitieren
APA
Li, G. G., Chu, X. F., Xing, Y. M., Xue, X., Ihtisham, B., Liang, X. F., Xu, J. X., Mi, Y., & Zheng, P. Y. (2024). Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression. Chinese Journal of Integrative Medicine. https://doi.org/10.1007/s11655-024-4109-6
Vancouver
Li GG, Chu XF, Xing YM, Xue X, Ihtisham B, Liang XF, et al. Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression. Chinese Journal of Integrative Medicine. 2024. doi:10.1007/s11655-024-4109-6
BibTeX
@article{Li2024,
author = {Li, Gang-Gang and Chu, Xiu-Feng and Xing, Ya-Min and Xue, Xia and Ihtisham, Bukhari and Liang, Xin-Feng and Xu, Ji-Xuan and Mi, Yang and Zheng, Peng-Yuan},
title = {Baicalin Prevents Colon Cancer by Suppressing CDKN2A Protein Expression},
journal = {Chinese Journal of Integrative Medicine},
year = {2024},
doi = {10.1007/s11655-024-4109-6}
}
EUVIMED